MannKind Corporation

MannKind Corporation (Nasdaq:MNKD ) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Our lead investigational product candidate, the Technosphere® Insulin System, is currently in Phase 3 clinical trials in the U.S., Europe and Latin America to study its safety and efficacy in the treatment of diabetes.

Additional recommended knowledge

Correct Test Weight Handling Guide: 12 Practical Tips

How to quickly check pipettes?

Weighing the right way

MannKind is focusing on three areas.

    First, we are continuing to execute the Technosphere® Insulin clinical trial program.

    Second, we are moving our second potential product – a therapeutic cancer vaccine
    – through Phase 1 clinical trials.

    Third, we have begun clinical testing of the next product candidate for use with our
    Technosphere® platform technology.

http://www.mannkindcorp.com